Effect of bariatric surgery on the pharmacokinetics of drugs used for attention‐deficit hyperactivity disorder—A case series
Bariatric surgery may increase the systemic exposure of dexamphetamine after intake of lisdexamphetamine. Patients using lisdexamphetamine should be followed with regard to adverse drug reactions after bariatric surgery, and, if available, therapeutic drug monitoring should be considered.
Authors
- Hege‐Merete Krabseth (ORCID: https://orcid.org/0009-0001-9342-582X)
- Olav Spigset (ORCID: https://orcid.org/0000-0001-7902-9014)
- Magnus Strømmen (ORCID: https://orcid.org/0000-0002-4686-0263)
- Arne Helland (ORCID: https://orcid.org/0000-0002-9373-1253)
Institutions
- Norwegian University of Science and Technology (NO)
- St Olav's University Hospital (NO)
Publication Details
- Journal
- Basic & Clinical Pharmacology & Toxicology
- Published
- 2024-11-04
- DOI
- https://doi.org/10.1111/bcpt.14099
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Norges Teknisk-Naturvitenskapelige Universitet
- Universitätsklinikum Tübingen